We are the first company in the world to develop and test an innovative new buffer system for our ophthalmic formulations that consistently maintains a neutral pH right throughout the shelf-life of the product despite temperature fluctuations. We call this ‘Dynamic Buffer Technology’.

Our Research Teams have taken over 2 years to develop and over 1 year to test this innovative new system in several of our ophthalmic formulations.

A consistently neutral pH formulation should, in theory give minimal ocular irritation and improved patient compliance. However several additional studies are underway to establish the effect of this buffer on Patient Compliance, Corneal absorption and Bioavailability.

To date this technology in incorporated in 3 of our ophthalmic formulations, and the doctor/patient feedback we have so far received is very encouraging.


Disclaimer: Any product related information is intended for medical practitioners only.